Keep track of Intently (one)pentobarbital will minimize the extent or impact of buprenorphine subdermal implant by affecting hepatic/intestinal enzyme CYP3A4 metabolism. Modify Therapy/Watch Closely. Observe clients previously on buprenorphine subdermal implant who demand recently-initiated therapy with CYP3A4 inducer for signs and signs or symptom